Univ. Lille, Lille, France.
CNRS UMR 8204, Lille, France.
PLoS One. 2018 Oct 11;13(10):e0204861. doi: 10.1371/journal.pone.0204861. eCollection 2018.
The whooping cough agent Bordetella pertussis coordinately regulates the expression of its virulence factors with the two-component system BvgAS. In laboratory conditions, specific chemical modulators are used to trigger phenotypic modulation of B. pertussis from its default virulent Bvg+ phase to avirulent Bvg- or intermediate Bvgi phases, in which no virulence factors or only a subset of them are produced, respectively. Whether phenotypic modulation occurs in the host remains unknown. In this work, recombinant B. pertussis strains harboring BvgS variants were tested in a mouse model of infection and analyzed using transcriptomic approaches. Recombinant BP-BvgΔ65, which is in the Bvgi phase by default and can be up-modulated to the Bvg+ phase in vitro, could colonize the mouse nose but was rapidly cleared from the lungs, while Bvg+-phase strains colonized both organs for up to four weeks. These results indicated that phenotypic modulation, which might have restored the full virulence capability of BP-BvgΔ65, does not occur in mice or is temporally or spatially restricted and has no effect in those conditions. Transcriptomic analyses of this and other recombinant Bvgi and Bvg+-phase strains revealed that two distinct ranges of virulence gene expression allow colonization of the mouse nose and lungs, respectively. We also showed that a recombinant strain expressing moderately lower levels of the virulence genes than its wild type parent was as efficient at colonizing both organs. Altogether, genetic modifications of BvgS generate a range of phenotypic phases, which are useful tools to decipher host-pathogen interactions.
百日咳杆菌协调其毒力因子的表达与双组分系统 BvgAS。在实验室条件下,使用特定的化学调节剂来触发百日咳杆菌从默认的毒力 Bvg+相到无毒力 Bvg-或中间 Bvgi 相的表型调节,分别为不产生毒力因子或仅产生部分毒力因子。表型调节是否发生在宿主中尚不清楚。在这项工作中,携带 BvgS 变体的重组百日咳杆菌菌株在感染小鼠模型中进行了测试,并使用转录组学方法进行了分析。重组 BP-BvgΔ65 默认处于 Bvgi 相,可在体外上调至 Bvg+相,可定植于小鼠鼻腔,但很快从肺部清除,而 Bvg+-相菌株可定植于两个器官长达四周。这些结果表明,表型调节可能恢复了 BP-BvgΔ65 的全部毒力能力,但在小鼠中不会发生,或者在时间或空间上受到限制,并且在这些条件下没有效果。对该重组 Bvgi 和 Bvg+-相菌株以及其他重组 Bvgi 和 Bvg+-相菌株的转录组分析表明,两个不同范围的毒力基因表达允许分别定植于小鼠鼻腔和肺部。我们还表明,与野生型亲本相比表达中等水平降低的毒力基因的重组菌株在定植两个器官方面同样有效。总之,BvgS 的遗传修饰产生了一系列表型阶段,这些阶段是解析宿主-病原体相互作用的有用工具。